This constant engagement helps in compliance to treatment and safety particularly during the early stages of treatment
Sun B, Willard FS, Feng D, Alsina-Fernandez J, Chen Q, Vieth M, Ho JD, Showalter AD, Stutsman C, Ding L, Suter TM, Dunbar JD, Carpenter JW, Mohammed FA, Aihara E, Brown RA, Bueno AB, Emmerson PJ, Moyers JS, Kobilka TS
FDA Information Sheet
Description This lyophilized compound is classified as a research chemical peptide and is intended strictly for laboratory use
A single-arm clinical trial found minimal amelioration in both ASD-related behaviors and fecal microbiome diversity with 28 GR plus myrosinase tablets/day depending on body weight (36), and one study found no difference in behavioral measures between treatment and placebo groups with 50 mol/day (38)